1-5 of 5
Michael W. Parker
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Drugging MYCN Oncogenic Signaling through the MYCN-PA2G4 Binding Interface

Jessica Koach, Jessica K. Holien, Hassina Massudi, Daniel R. Carter, Olivia C. Ciampa, Mika Herath, Taylor Lim, Janith A. Seneviratne, Giorgio Milazzo, Jayne E. Murray, Joshua A. McCarroll, Bing Liu, Chelsea Mayoh, Bryce Keenan, Brendan W. Stevenson, Michael A. Gorman, Jessica L. Bell, Larissa Doughty, Stefan Hüttelmaier, Andre Oberthuer, Matthias Fischer, Andrew J. Gifford, Tao Liu, Xiaoling Zhang, Shizhen Zhu, W. Clay Gustafson, Michelle Haber, Murray D. Norris, Jamie I. Fletcher, Giovanni Perini, Michael W. Parker, Belamy B. Cheung, Glenn M. Marshall
Journal: Cancer Research
Series: Author Choice
Cancer Res (2019) 79 (21): 5652–5667.
https://doi.org/10.1158/0008-5472.CAN-19-1112
Published: 01 November 2019
View articletitled, Drugging MYCN Oncogenic Signaling through the MYCN-PA2G4 Binding Interface
Open the PDF for Drugging MYCN Oncogenic Signaling through the MYCN-PA2G4 Binding Interface in another window
Includes: Supplementary data
Journal Articles

Abstract 4962: Repurposing bazedoxifene to suppress gastrointestinal cancer growth

Pathum Thilakasiri, Tracy Nero, Michael W. Parker, Matthias Ernst, Ashwini L. Chand
Journal: Cancer Research
Cancer Res (2019) 79 (13_Supplement): 4962.
https://doi.org/10.1158/1538-7445.AM2019-4962
Published: 01 July 2019
View articletitled, Abstract 4962: Repurposing bazedoxifene to suppress gastrointestinal cancer growth
Journal Articles

Abstract 5371: PRMT5 inhibitors as novel treatment for cancers

Hendrik Falk, Richard C. Foitzik, Elizabeth Allan, Melanie deSilva, Hong Yang, Ylva E. Bozikis, Marica Nikac, Scott R. Walker, Michelle A. Camerino, Ben J. Morrow, Alexandra E. Stupple, Rachel Lagiakos, Jo-Anne Pinson, Romina Lessene, Wilhelmus JA Kersten, Danny G. Ganame, Ian P. Holmes, Gill E. Lunniss, Matthew Chung, Stefan J. Hermans, Michael W. Parker, Alison Thistlethwaite, Karen White, Susan A. Charman, Brendon J. Monahan, Patricia Pilling, Julian Grusovin, Thomas S. Peat, Stefan Sonderegger, Emma Toulmin, Stephen M. Jane, David J. Curtis, Paul A. Stupple, Ian P. Street
Journal: Cancer Research
Cancer Res (2015) 75 (15_Supplement): 5371.
https://doi.org/10.1158/1538-7445.AM2015-5371
Published: 01 August 2015
View articletitled, Abstract 5371: PRMT5 inhibitors as novel treatment for cancers
Journal Articles

Abstract A19: The selective targeting of cell survival pathways in leukemia

Daniel Thomas, Jason A. Powell, Michael W. Parker, Paul G. Ekert, Richard B. Lock, David CS Huang, Susie K. Nilsson, Christian Recher, Andrew H. Wei, Mark A. Guthridge
Journal: Cancer Research
Cancer Res (2013) 73 (19_Supplement): A19.
https://doi.org/10.1158/1538-7445.FBCR13-A19
Published: 15 May 2014
View articletitled, Abstract A19: The selective targeting of cell survival pathways in leukemia
Journal Articles

Abstract 469: CD151 and cell motility in prostate cancer

Sujitra Detchokul, Michael W. Parker, Elizabeth D. Williams, Olivia M. Herdiman, Melissa Davis, Kelvin Kee, Damien M. Bolton, Albert G. Frauman
Journal: Cancer Research
Cancer Res (2012) 72 (8_Supplement): 469.
https://doi.org/10.1158/1538-7445.AM2012-469
Published: 15 April 2012
View articletitled, Abstract 469: CD151 and cell motility in prostate cancer